Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
XENE

Xenon Pharmaceuticals

, AMGN

Amgen

$170.77

1.39 (0.82%)

14:29
11/17/17
11/17
14:29
11/17/17
14:29
Periodicals
Xenon higher as CNBC's Tirrell reports on nonaddictive pain medicines »

Six drug companies are…

XENE

Xenon Pharmaceuticals

AMGN

Amgen

$170.77

1.39 (0.82%)

RHHBY

Roche

$28.90

0.165 (0.57%)

BIIB

Biogen

$313.98

3.7 (1.19%)

RGEN

Repligen

$33.73

1.12 (3.43%)

VRTX

Vertex

$147.94

-0.72 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 23

    Dec

  • 03

    Feb

  • 23

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

Thursday
SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:49
11/16/17
11/16
13:49
11/16/17
13:49
Recommendations
Shire, Roche analyst commentary at Cantor Fitzgerald »

Roche's black box…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

SHPG

Shire

$140.03

0.76 (0.55%)

, RHHBY

Roche

$28.73

-0.12 (-0.42%)

13:13
11/16/17
11/16
13:13
11/16/17
13:13
Recommendations
Shire, Roche, Bioverativ analyst commentary at RBC Capital »

Roche approval neutral to…

SHPG

Shire

$140.03

0.76 (0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

BIVV

Bioverativ

$55.18

0.79 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

12:36
11/16/17
11/16
12:36
11/16/17
12:36
Hot Stocks
Genentech announces FDA approval of Gazyva in combination with chemotherapy »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

11:55
11/16/17
11/16
11:55
11/16/17
11:55
Periodicals
Roche tells Bloomberg Hemlibra priced at $482K for first year »

A Roche spokesperson told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

11:16
11/16/17
11/16
11:16
11/16/17
11:16
Hot Stocks
Genentech says FDA approves Hemlibra for Hemophilia A with inhibitors »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

11:05
11/16/17
11/16
11:05
11/16/17
11:05
Hot Stocks
Roche unit wins FDA approval for hemophilia A treatment »

The FDA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

10:51
11/16/17
11/16
10:51
11/16/17
10:51
Hot Stocks
Breaking Hot Stocks news story on Roche »

FDA approves Roche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 30

    Nov

  • 23

    Dec

  • 23

    Feb

RHHBY

Roche

$28.73

-0.12 (-0.42%)

, ABBV

AbbVie

$93.76

-0.99 (-1.04%)

05:33
11/16/17
11/16
05:33
11/16/17
05:33
Recommendations
Roche, AbbVie, Novartis, Bayer, Johnson & Johnson, Zoetis, Eli Lilly, Merck, Novo Nordisk, AstraZeneca analyst commentary at Jefferies »

Jefferies names Roche new…

RHHBY

Roche

$28.73

-0.12 (-0.42%)

ABBV

AbbVie

$93.76

-0.99 (-1.04%)

NVS

Novartis

$82.60

-0.43 (-0.52%)

BAYRY

Bayer

$31.97

-0.04 (-0.12%)

JNJ

Johnson & Johnson

$139.10

-0.39 (-0.28%)

ZTS

Zoetis

$69.62

-0.28 (-0.40%)

LLY

Eli Lilly

$82.19

-0.3 (-0.36%)

MRK

Merck

$54.80

-0.19 (-0.35%)

NVO

Novo Nordisk

$49.67

-0.17 (-0.34%)

AZN

AstraZeneca

$33.39

0.14 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 28

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 04

    Dec

  • 06

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 02

    Feb

  • 23

    Feb

  • 17

    May

SGMO

Sangamo

$14.65

1.75 (13.57%)

, MPX

Marine Products

$14.09

0.04 (0.28%)

04:55
11/16/17
11/16
04:55
11/16/17
04:55
Conference/Events
Jefferies to hold a conference »

Healthcare Conference is…

SGMO

Sangamo

$14.65

1.75 (13.57%)

MPX

Marine Products

$14.09

0.04 (0.28%)

WMGI

Wright Medical

$24.21

0.53 (2.24%)

SPPI

Spectrum

$19.66

0.86 (4.57%)

QGEN

QIAGEN

$30.68

-0.17 (-0.55%)

INCR

INC Research

$36.00

1.65 (4.80%)

JAZZ

Jazz Pharmaceuticals

$134.17

-0.07 (-0.05%)

MRTX

Mirati Therapeutics

$14.05

0.85 (6.44%)

NTEC

Intec Pharma

$7.45

-0.05 (-0.67%)

SYBX

Synlogic

$9.28

0.13 (1.42%)

NITE

Nightstar Therapeutics

ALBO

Albireo Pharma

$22.75

-0.97 (-4.09%)

CLLS

Cellectis

$23.33

-0.13 (-0.55%)

RHHBY

Roche

$28.73

-0.12 (-0.42%)

RTRX

Retrophin

$21.09

-0.25 (-1.17%)

RXDX

Ignyta

$15.00

-1 (-6.25%)

CRL

Charles River

$100.43

-0.49 (-0.49%)

VNDA

Vanda

$12.85

-0.1 (-0.77%)

PODD

Insulet

$67.86

0.44 (0.65%)

BRKR

Bruker

$32.39

-0.3 (-0.92%)

BMY

Bristol-Myers

$61.07

-0.18 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 17

    Nov

  • 28

    Nov

  • 29

    Nov

  • 30

    Nov

  • 30

    Nov

  • 30

    Nov

  • 01

    Dec

  • 05

    Dec

  • 09

    Dec

  • 14

    Dec

  • 23

    Dec

  • 23

    Feb

  • 05

    Mar

  • 16

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.